ENRIQUE
ALAVA CASADO
Chercheur dans le période 2012-2013
Hospital Universitario Virgen del Rocío
Sevilla, EspañaPublications en collaboration avec des chercheurs de Hospital Universitario Virgen del Rocío (8)
2019
-
Preclinical efficacy of endoglin-targeting antibody–drug conjugates for the treatment of Ewing sarcoma
Clinical Cancer Research, Vol. 25, Núm. 7, pp. 2228-2240
2017
-
GEIS-21: A multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: A report from the Spanish sarcoma group (GEIS)
British Journal of Cancer, Vol. 117, Núm. 6, pp. 767-774
2016
-
Molecular pathology of bone and soft tissue tumors
The Molecular Basis of Human Cancer (Springer New York), pp. 623-655
-
Sarcoma histiocítico en intestino delgado: estudio y discusión de un caso con reordenamiento clonal linfoide B
Revista Espanola de Patologia, Vol. 49, Núm. 4, pp. 254-258
2015
-
The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin
Oncotarget, Vol. 6, Núm. 22, pp. 18875-18890
2014
-
Characterization of human mesenchymal stem cells from Ewing sarcoma patients. Pathogenetic implications
PLoS ONE, Vol. 9, Núm. 2
-
Innovative therapies in ewing sarcoma
Advances in Anatomic Pathology, Vol. 21, Núm. 1, pp. 44-62
2010
-
Molecular predictors of efficacy of adjuvant weekly paclitaxel in early breast cancer
Breast Cancer Research and Treatment, Vol. 123, Núm. 1, pp. 149-157